#CancerVaccine
LightNews LightNews
rocits.bsky.social
Cancer Vaccine Breakthrough
#MRNA #Cancer #CancerVaccine

www.youtube.com/watch?v=3g2u...
Australia at the centre of 'transformational' cancer vaccine breakthrough | 7.30
YouTube video by ABC News In-depth
www.youtube.com
November 2, 2026 at 10:50 PM
springermedicine.com
From #ESMO2026 - Patients with stage IIB–IV cutaneous melanoma derive a significant recurrence-free survival benefit from adding a personalized mRNA-based #CancerVaccine to adjuvant pembrolizumab.

Full story 👉️ buff.ly/SNRpApq

#MedNews
Adjuvant treatment with mRNA melanoma vaccine reduces recurrence risk
Patients with stage IIB–IV cutaneous melanoma derive a significant recurrence-free survival benefit from adding a personalized mRNA-based cancer vaccine to adjuvant pembrolizumab.
www.springermedicine.com
November 2, 2026 at 4:15 PM
realfeedapp.com
Analysts reviewed clinical trial data to determine the actual effectiveness of Merck and Moderna mRNA vaccines against cancer.

#Mrna #CancerVaccine #ClinicalTrial
Researchers evaluate Merck and Moderna mRNA cancer vaccine efficacy
Source: STAT News
realfeedapp.com
October 30, 2026 at 3:20 PM
news.zovintus.com
Merck’s leadership remained remarkably unfazed after sensitive clinical data for their highly anticipated experimental cancer vaccine leaked early ahead of the ESMO congress, averting a typical corporate crisis.

#CancerVaccine #Pharma #Zovintus
[Image by AI]
Merck Executive Unfazed By Early ESMO Cancer Vaccine Leak
Your source for world news, technology insights, crypto market updates, science, and health. Explore deep investigative reporting on Zovintus Blog
blog.zovintus.com
October 28, 2026 at 8:29 PM
quartzmedia.bsky.social
AstraZeneca eyes cancer vaccines — but not the personalized kind #AstraZeneca #CancerVaccine
AstraZeneca eyes cancer vaccines — but not the personalized kind
AstraZeneca's CEO is signaling the pharma giant could enter the cancer vaccine space using mRNA tech, while drawing a clear line: it's eyeing broad, population-level vaccines rather than the personalized approach rivals like Merck and Moderna are racing to perfect. With scalability concerns and stiff competition, the company is betting on playing where it can win.
dlvr.it
October 28, 2026 at 7:52 AM
quartzmedia.bsky.social
AstraZeneca eyes cancer vaccines — but not the personalized kind #AstraZeneca #CancerVaccine
AstraZeneca eyes cancer vaccines — but not the personalized kind
AstraZeneca's CEO is signaling the pharma giant could enter the cancer vaccine space using mRNA tech, while drawing a clear line: it's eyeing broad, population-level vaccines rather than the personalized approach rivals like Merck and Moderna are racing to perfect. With scalability concerns and stiff competition, the company is betting on playing where it can win.
dlvr.it
October 28, 2026 at 7:52 AM
newsmason.bsky.social
#trends today for 'james bond' 'cancer vaccine' & 'mass effect'

Click/Tap below:

www.newsmason.com?query=%22jam...

www.newsmason.com?query=%22can...

www.newsmason.com?query=%22mas...

#jamesbond #cancervaccine #masseffect
www.newsmason.com
October 24, 2026 at 2:25 AM
romanpiso.bsky.social
#Discover #Science #Cancer #Melanoma #CancerVaccine

www.yahoo.com/news/science...
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
WASHINGTON (AP) — A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmake...
www.yahoo.com
October 23, 2026 at 3:49 AM
replaye.bsky.social
Moderna shares plunge after cancer vaccine data leaks — despite positive results
replaye.com/moderna-shar...

#News #Moderna #CancerVaccine #Vaccine #Cancer
Moderna shares plunge after cancer vaccine data leaks — despite positive results - Replaye
Moderna released full data on its closely watched cancer vaccine developed with Merck.
replaye.com
October 23, 2026 at 7:44 PM
robertcfried.bsky.social
#CancerResearch #CancerVaccine #mRNA #Melanoma #Immunotherapy #PersonalizedMedicine #ClinicalTrials #CancerTreatment #Moderna #Merck #Keytruda #MedicalResearch #Oncology #HealthNews #APNews
October 23, 2026 at 7:08 AM
ktve10kard14.bsky.social
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.
#YourArkLaMissNewsSource #cancervaccine #melanoma
Read Here: https://tinyurl.com/mzt44uau 
Image 1
October 23, 2026 at 6:30 PM
pharmaphorum.bsky.social
#Moderna and #MSD have shared keenly anticipated results for their #melanoma #cancervaccine, ahead of a presentation at #ESMO26 tomorrow, after a data #embargo #breach.

pharmaphorum.com/news/esmo26-...
October 23, 2026 at 8:29 AM
earthinsider.bsky.social
New mRNA Cancer Vaccine Data Shows Why Doctors Are Rethinking Relapse Defense

Full story 👇

Learn more: https://www.earthinsider.in/2026/10/mrna-cancer-vaccine-melanoma-recurrence.html

#EarthInsider #EarthInsiderNews #EINews #Global #WorldNews #GlobalAffairs #CancerVaccine #mRNA #Melanoma
October 23, 2026 at 4:03 AM
aussmc.bsky.social
💉 An mRNA-based cancer vaccine has been shown to reduce the risk of death or of the cancer coming back by 42%

🗨️comments from @burnetinstitute.bsky.social @centenaryinstitute.bsky.social @wehi-research.bsky.social

www.scimex.org/newsfeed/exp...

#cancervaccine #mRNA #melanoma #skincancer #Cancer
October 23, 2026 at 2:50 AM
lisamariepane.bsky.social
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
apnews.com/article/mode...
#mRNA #cancervaccine @apnews.com
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
apnews.com
October 23, 2026 at 12:03 AM
puretech.news
These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free #Technology #Business #melanoma #merck #moderna #cancervaccine #clinicaltrial
These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free
An apparent leak prompted Merck and Moderna to release the full trial results ahead of schedule, but investors puzzlingly greeted the good news by sending the companies’ stock prices down.
puretech.news
October 23, 2026 at 2:17 PM
earthinsider.bsky.social
New mRNA Cancer Vaccine Data Shows Why Doctors Are Rethinking Relapse Defense

Full story 👇

Learn more: https://www.earthinsider.in/2026/10/mrna-cancer-vaccine-melanoma-recurrence.html

#EarthInsider #EarthInsiderNews #EINews #Global #WorldNews #GlobalAffairs #CancerVaccine #mRNA #Melanoma
mRNA Cancer Vaccine Trial Signals a Turning Point in Skin Cancer Care
New mRNA cancer vaccine clinical trials could alter melanoma care forever, impacting millions facing relapse risks. Find out what happened.
www.earthinsider.in
October 23, 2026 at 3:50 AM
quartzmedia.bsky.social
ICYMI: A personalized cancer vaccine could reach patients faster — here's what's next #CancerVaccine #PrecisionMedicine
A personalized cancer vaccine could reach patients faster — here's what's next
Merck and Moderna's custom cancer vaccine — tailored to each patient's tumor mutations — currently takes six weeks to manufacture, but Merck's CEO says that timeline will shrink. After hitting a key Phase 3 milestone in melanoma patients, the companies are now expanding trials to lung, bladder, and kidney cancers.
dlvr.it
October 16, 2026 at 12:01 AM
quartzmedia.bsky.social
A personalized cancer vaccine could reach patients faster — here's what's next #CancerVaccine #PersonalizedMedicine
A personalized cancer vaccine could reach patients faster — here's what's next
Merck and Moderna's custom cancer vaccine — tailored to each patient's tumor mutations — currently takes six weeks to manufacture, but Merck's CEO says that timeline will shrink. After hitting a key Phase 3 milestone in melanoma patients, the companies are now expanding trials to lung, bladder, and kidney cancers.
dlvr.it
October 14, 2026 at 11:59 PM
kimdefalco.bsky.social
"It tested a novel vaccine, based on Penn’s groundbreaking mRNA research, that trains the patient’s immune system to find and kill cancer cells.That technology has become the first mRNA cancer vaccine to succeed in a late-stage clinical trial."

#science #cancervaccine #PennMedicine
Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
Penn helped test an mRNA cancer vaccine that succeeded in its late-stage clinical trial. “This was kind of the wake-up call that RNA vaccines in cancer have an enormous future,” Drew Weissman said.
www.inquirer.com
September 25, 2026 at 5:32 PM
quartzmedia.bsky.social
ICYMI: A cancer vaccine built for one person. Can it scale for millions? #CancerVaccine #PersonalizedMedicine
A cancer vaccine built for one person. Can it scale for millions?
Merck and Moderna just proved a personalized mRNA cancer vaccine can keep melanoma from coming back — but each dose is custom-built from a single patient's tumor mutations, flipping drug manufacturing on its head. The science works; now comes the harder problem of making it fast, affordable, and widely available.
dlvr.it
September 23, 2026 at 1:21 PM
quartzmedia.bsky.social
A cancer vaccine built for one person. Can it scale for millions? #CancerVaccine #PersonalizedMedicine
A cancer vaccine built for one person. Can it scale for millions?
Merck and Moderna just proved a personalized mRNA cancer vaccine can keep melanoma from coming back — but each dose is custom-built from a single patient's tumor mutations, flipping drug manufacturing on its head. The science works; now comes the harder problem of making it fast, affordable, and widely available.
dlvr.it
September 22, 2026 at 1:21 PM
robertlufkinmd.bsky.social
#CancerVaccine #mRNA #Melanoma #HealthLongevitySecrets #RobertLufkin (3/3)
September 8, 2026 at 12:53 PM
thebabaklab.bsky.social
Merck and Moderna have announced positive top-line results from the Phase 3 INTerpath-001 trial of intismeran autogene (V940) + pembrolizumab in patients with resected high-risk melanoma.

Link in the comments 👇

#ClinicalMondays #Melanoma #CancerVaccine #mRNA #Immunotherapy
September 7, 2026 at 4:43 PM
thecancersurvivorsclub.com
A personalised cancer vaccine moves another step closer. A late-stage trial of an mRNA vaccine tailored to each patient’s tumour has shown it can reduce the risk of melanoma returning or spreading.

www.ucsf.edu/news/2026/08...

#Melanoma #CancerVaccine #CancerResearch #TCSC
Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era
UCSF researchers helped test the first personalized mRNA cancer vaccine shown to prevent melanoma from returning or spreading, marking a breakthrough in cancer treatment.
www.ucsf.edu
September 3, 2026 at 7:46 AM